ISSN: 2375-3838
International Journal of Clinical Medicine Research  
Manuscript Information
 
 
Marginal Zone Lymphoma with Central Nervous System Spread – A Case Report
International Journal of Clinical Medicine Research
Vol.1 , No. 2, Publication Date: Jul. 7, 2014, Page: 31-34
1626 Views Since July 7, 2014, 1431 Downloads Since Apr. 14, 2015
 
 
Authors
 
[1]    

Jason SF Cabot , Royal College of Medicine Perak, University of Kuala Lumpur, Ipoh, Malaysia.

[2]    

Nadiah K Paramasivam , Royal College of Medicine Perak, University of Kuala Lumpur, Ipoh, Malaysia.

[3]    

Padmini Menon , Ipoh General Hospital, Ipoh, Malaysia.

 
Abstract
 

Parenchymal central nervous system (CNS) presentation or spread of marginal zone lymphoma (MZL) is a rare event. We report a case of 55-year old patient who presented initially with a MZL of the right breast with widespread lymphadenopathy that responded well to immune-chemotherapy, who subsequently relapsed approximately 18 months later with a solitary CNS parenchymal lesion. We review the literature of both breast and CNS presentation of lymphomas.


Keywords
 

B-Cell Lymphoma, Extra-Nodal, Marginal Zone Lymphoma, Non-Hodgkin’s Lymphoma, Breast Lymphoma, Central Nervous System Lymphoma


Reference
 
[01]    

Marginal Zone Lymphoma. Lymphoma Research Foundation (20. Retrieved from: http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=6554677

[02]    

Murphy JK, O’Brien CJ, Ironside JW. Morphologic and immunophenotypic characterization of primary brain lymphomas using paraf-fin-embedded tissue. Histopathology 1989;15:449-60.

[03]    

O’Neill BP, Illig JJ: Primary central nervous system lymphoma. Mayo Clinic Proc 1989;64:1005-1020.

[04]    

Herman TS, Hammond N, Jones SE et al. Involvement of the central nervous system by non-Hodgkin’s lymphoma. The Southern Oncology Group Expe-rience. Cancer. 1979;43:390-7.

[05]    

Levitt LJ, Dawson DM, Rosenthal DS, et al. CNS involvement in the non-Hodgkin’s lymphomas. Cancer 1980; 45: 545-52.

[06]    

Mackintosh, FR, Colby TV, Podolsky WJ et al. Central nervous system involvement in non-Hodgkin’s lymphoma: an analysis of 105 cases. Cancer 1982; 49: 586-95.

[07]    

Recht L, Straus DJ, Cirrincione C et al. Central nervous system metastases from non-Hodgkin’s lymphoma: treatment and prophylaxis. Am J Med 1988; 84: 425-35.

[08]    

Bashir RM, Bierman PJ, Vose JM et al. Central nervous system involvement in patients with diffuse aggressive non-Hodgkin’s lymphoma. Am J Cli-nOncol 1991;14:478-82

[09]    

Hollender A, Kvaloy S, Lote K et al. Prognostic factors in 140 adult patients with non-Hodgkin’s lymphoma with systemic central nervous system (CNS) involvement: a single center analysis. Eur J Cancer 2000; 36: 1762-8.

[10]    

Bayraktar S, Stefanovic A, Montague N, et al. Central nervous system manifestations of marginal zone B-call lymphoma. Ann Hematol. 2010; 10: 1003-9

[11]    

Kumar S, Kumar D, Kaldjian EP, et al. Primary low grade B-cell lymphoma of the dura: A mucosa associated lymphoid tissue-type lymphoma. Am J SurgPathol 1997;21:81-7

[12]    

Kambham N, Chang Y, Matsushima AY: Primary low-grade B cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura. Clin Neuropath 1998;17:311-17

[13]    

Rottnek M, Strauchen J, Moore F, et al. Primary dural mucosa-associated lymphoid tissue-type lymphoma: Case report and review of literature. J Neurooncol 2004;68:19-23.

[14]    

Goetz P, Lafuente J, Revesz T, et al: Primary low-grade B-cell lymphoma of mucoas-associated lymphoid tissue of dura mimicking the presentation of an acute subdural hematoma. Case report and review of the literature. J Neurosurg 2002;96:611-14.

[15]    

Sanjeevi A, Krishnan J, Bailey PR, et al. Extranodal marginal zone B-cell lymphoma of the MALT type involcving the cavernous sinus. Leuk Lymphoma 2001;42:1133-7.

[16]    

Itoh T, Shimizu M, Kitami K, et al. Primary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in CNS. Neuropathology 2001;21:174-80.

[17]    

Altundag MK, Ozisik Y, Yalcin S, et al. Primary low grade B-cell lymphoma of the dura in an immunocompetent patient. J ExpClin Cancer Res 2000;19:249-51.

[18]    

Ancheta RG, Lewin H, Said J, et al. Primary dural marginal zone lymphoma in a woman with inflammatory breast cancer. J ClinOnc. 2008; 26: 326-8.

[19]    

Ghasem J, Shaghayegh K et al: Bilateral breast swelling in a 23-year old women with Burkitt lymphoma. Journal of Research in Medical Sciences 2012; 17(: 1188-1191.

[20]    

Hugh JC, Jackson FI, Hanson J et al. Primary breast lymphoma. An immunohis-tologic study of 20 new cases. Cancer 1990;66:2602-11

[21]    

Joks M, mysliwiec K, Lewandowski K. Primary breast lymphoma: A review of the literature and report of three cases. Arch Med Sci. 2011;7:27-33.

[22]    

Liberman L, Giess CS, Dershaw DD. Et al. Non-Hodgkin lymphoma of the breast: Imaging characteristics and correlation with histopathologic findings. Radiology. 1994;192: 157-60.

[23]    

Darnell A, Gallardo X, Sentis M, et al. Primary lymphoma of the breast: MR imaging features. A case report. MagnReson Imaging. 1999;17:479-82

[24]    

Barista I, Baltali E, Tekuzman G, et al. Primary breast lymphomas: A retros-pective analysis of twelve cases. ActaOnco. 2000;39:135-9.

[25]    

Brogi E, Harris NL. Lymphomas of the breast: Pathology and clinical behaviour. Sem in Oncol. 1999;26:357-64

[26]    

Domchek SM, Hecht JL, Fleming MD, et a. Lymphomas of the breast: Primary and secondary involvement. Cancer. 2002;94:6-13.

[27]    

Schouten JT, Weese JL, Carbone PP. Lymphoma of the breast. Ann Surg. 1981:194;749-53.

[28]    

Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer 1972;29:1705-12

[29]    

Hugh JC, Jackson FI, Hanson J, et al. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer. 1990;66:2602-11

[30]    

Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin’s lymphomas of the female breast. Cancer. 1992;69:725-35

[31]    

Sabate JM, Gomez, A, Torrubia S, et al. Lymphoma of the breast: Clinical and radiologic features with pathologic correlation in 28 patients. Breast J. 2002:8:294-304.

[32]    

Kambouchner, M, Godmer P, Guillevin L, et al. Low grade marginal zone B cell lymphoma of the breast associated with localised amyloidosis and cororaamylacea in a woman with long standing primary Sjogren’s syndrome. J ClinPathol. 2003; 56:74-7.

[33]    

Soyupak SK, Sire D et al. Secondary involvement of breast with non-Hodgkin’s lymphoma in apaediatric patient presenting as bilateral masses. EurRadiol. 2000;10:519-20

[34]    

Brustein S, Filippa DA et al. Malignant lymphoma of the breast. A study pf 53 patients. Ann Surg. 1987;205:144-50.

[35]    

Ha CS, Dubey P et al. Localized primary non-Hodgkin lymphoma of the breast. Am J ClinOncol. 1998;21:376-80.

[36]    

Telesinghe PU, Anthony PP. Primary lymphoma of the breast. Histopathology. 1985;9:297-307.

[37]    

Ryan GF, Roos DR et al. Primary non-Hodgkin;s lymphoma of the breast: Retrospective analysis of prognosis and patterns of failure in two Australian centres. Clin Lymphoma Myeloma. 2006;6:337-41.

[38]    

Hollender A, Kvaloy S, Lote K et al. CNS involvement following diagnosis of non_Hodgkin’s lymphoma: risk model. Annals of Oncology. 2002;13:1099-11%





 
  Join Us
 
  Join as Reviewer
 
  Join Editorial Board
 
share:
 
 
Submission
 
 
Membership